338 results on '"Bross, Peter"'
Search Results
2. A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer
3. Microvessel and mitochondria changes in a mouse model of Alzheimer’s disease
4. The psychiatric risk gene BRD1 modulates mitochondrial bioenergetics by transcriptional regulation
5. An inventory of interactors of the human HSP60/HSP10 chaperonin in the mitochondrial matrix space
6. Potential complementation effects of two disease-associated mutations in tetrameric glutaryl-CoA dehydrogenase is due to inter subunit stability-activity counterbalance
7. Deficiency of the mitochondrial sulfide regulator ETHE1 disturbs cell growth, glutathione level and causes proteome alterations outside mitochondria
8. APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells
9. Mitochondrial Hsp70 and the troubles of nomenclature: leaving behind tradition to gain intuitiveness and clarity
10. Regulation of biologic oncology products in the FDA׳s Center for Biologics Evaluation and Research
11. Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system
12. Do lamin A and lamin C have unique roles?
13. A cell model to study different degrees of Hsp60 deficiency in HEK293 cells
14. Effects of a mutation in the HSPE1 gene encoding the mitochondrial co-chaperonin HSP10 and its potential association with a neurological and developmental disorder
15. Inactivation of the hereditary spastic paraplegia-associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in mice
16. Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients
17. Metabolic profiling of heat or anoxic stress in mouse C2C12 myotubes using multinuclear magnetic resonance spectroscopy
18. Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia
19. Introduction
20. Energy metabolism adaptations and gene expression reprogramming in a cellular MAFLD model
21. Heterozygosity for an in-frame deletion causes glutaryl-CoA dehydrogenase deficiency in a patient detected by newborn screening: investigation of the effect of the mutant allele
22. Mitochondrial fatty acid oxidation defects—remaining challenges
23. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level
24. Mitochondrial Hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy
25. Single-nucleotide variations in the genes encoding the mitochondrial Hsp60/Hsp10 chaperone system and their disease-causing potential
26. Protein misfolding, aggregation, and degradation in disease
27. Association Between Low Self-Rated Health and Heterozygosity for −110A > C Polymorphism in the Promoter Region of HSP70-1 in Aged Danish Twins
28. LEFT MAIN CORONARY ARTERY COMPRESSION BY AORTIC ABSCESS DIAGNOSED BY INTRAVASCULAR ULTRASOUND
29. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter
30. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins
31. Leptin regulation of Hsp60 impacts hypothalamic insulin signaling
32. Mutated Desmoglein-2 Proteins are Incorporated into Desmosomes and Exhibit Dominant-Negative Effects in Arrhythmogenic Right Ventricular Cardiomyopathy
33. Clinical characteristics and symptom duration among outpatients with COVID-19.
34. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report
35. Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations
36. Glycosylation of the N-terminal potential N- glycosylation sites in the human α1,3- fucosyltransferase V and -VI (hFucTV and -VI)
37. Human and mouse mitochondrial orthologs of bacterial ClpX
38. Characterization of mouse Clpp protease cDNA, gene, and protein
39. Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency
40. Drug–diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop
41. Structural organization of the human short-chain acyl-CoA dehydrogenase gene
42. Heat-Shock Protein 70 Genes and Human Longevity: A View from Denmark
43. Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation
44. The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MS-based newborn screening, is temperature sensitive
45. Genetic defects in fatty acid β-oxidation and acyl-CoA dehydrogenases: Molecular pathogenesis and genotype–phenotype relationships
46. Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E. coli
47. Protein Quality Control in the Endoplasmic Reticulum
48. [small alpha, Greek]-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
49. The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope
50. The clinical outcome of LMNA missense mutations appears to be associated with the amount of mutated protein in the nuclear envelope
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.